Product Information
DABIGATRAN ETEXILATE 75 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8983 per EA under NDC 62332063406. Its NADAC has been published 81 times since Dec 11, 2024.
Strength
75 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332063406
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DABIGATRAN ETEXILATE MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA215233On Market Since
6/14/2024
Pharmacological Classes
Price Statistics
The NADAC for DABIGATRAN ETEXILATE 75 MG CAP has been published 81 times since Dec 11, 2024, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8983 per EA |
|---|---|
| All-time high | $2.1906 (Dec 11, 2024) |
| All-time low | $0.8478 (Apr 22, 2026) |
| 52-week high | $1.4699 |
| 52-week low | $0.8478 |
| Median price | $1.1261 |
| Average price | $1.3338 |
| Largest weekly change | -11.0% (Aug 20, 2025) |
| Weeks tracked | 81 |
| Tracking since | Dec 11, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DABIGATRAN ETEXILATE 75 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 75 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.8983 per EA (NDC 62332063406), effective Jun 24, 2026.
How has the price of DABIGATRAN ETEXILATE 75 MG CAP changed over time?
Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has declined 59.0%. It has been tracked across 81 weekly CMS publications since Dec 11, 2024.
What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 75 MG CAP?
Since Dec 11, 2024, the NADAC for DABIGATRAN ETEXILATE 75 MG CAP has ranged from a low of $0.8478 (Apr 22, 2026) to a high of $2.1906 (Dec 11, 2024), with a median of $1.1261 per EA.
Are there cheaper alternatives to DABIGATRAN ETEXILATE 75 MG CAP?
5 NADAC-published products share the same active ingredient, strength, and dosage form as DABIGATRAN ETEXILATE 75 MG CAP, but none are currently priced below it.
Who manufactures DABIGATRAN ETEXILATE 75 MG CAP?
DABIGATRAN ETEXILATE 75 MG CAP (NDC 62332063406) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification